December 15th 2023
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
September 18th 2023
2024 Neuromuscular Summit
November 20, 2024
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Cover Story: Repeat antenatal corticosteroids: A time for caution
August 1st 2002While a single course of antenatal corticosteroids improves neonatal outcomes among infants born prematurely, the efficacy and safety of repetitive courses of ACS (including rescue dosing) is less clear. In the absence of adequate data to support a policy of repetitive dosing of ACS, such therapy should only be used as part of well-designed clinical trials.
Read More
Cover Story: Abnormal uterine bleeding in the perimenopausal patient
April 1st 2002Endometrial biopsy, vaginal ultrasound, and sonohysteroscopy are among the diagnostic procedures to consider in this patient population. Treatment options must be individualized based on the patient's history and each therapy's benefit/risk profile.
Read More
CME: A gynecologist's guide to acne
January 1st 2002Gynecologists are in an ideal position to evaluate patients--particularly teens--for hyperandrogenism and initiate hormonal and nonhormonal treatment of acne. Topical therapy is appropriate first-line therapy and OCs are also an important part of the armamentarium.
Read More
CME: Endometrial intraepithelial neoplasia:new standard for diagnosing precancer
May 1st 2001Recent research has provided gynecologic pathologists with new information about endometrial hyperplasias. These findings have allowed clinicians to devise a new tool for the diagnosis of precancer: the EIN classification system.
Read More
CME: Offering mifepristone as an abortion option
February 1st 2001While family planning clinics are hailing the FDA's recent approval of mifepristone (RU-486) as a noninvasive way to terminate an unwanted pregnancy, ob/gyns who decide to administer the drug need to familiarize themselves with the research on its advantages and disadvantages.
Read More